Geva R - Search Results

1

Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations.

Ofir Dovrat T, Sokol E, Frampton G, Shachar E, Pelles S, Geva R, Wolf I. Ofir Dovrat T, et al. Among authors: geva r. Cancer Biol Ther. 2018;19(10):871-874. doi: 10.1080/15384047.2018.1480289. Epub 2018 Jul 23. Cancer Biol Ther. 2018. PMID: 30036146 Free PMC article.

2

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.

3

Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.

Barenboim A, Lahat G, Geva R, Nachmany I, Nakache R, Goykhman Y, Brazowski E, Rosen G, Isakov O, Wolf I, Klausner JM, Lubezky N. Barenboim A, et al. Among authors: geva r. Eur J Surg Oncol. 2018 Oct;44(10):1619-1623. doi: 10.1016/j.ejso.2018.07.057. Epub 2018 Aug 2. Eur J Surg Oncol. 2018. PMID: 30146251

4

Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors.

Barenboim A, Lahat G, Nachmany I, Nakache R, Goykhman Y, Geva R, Osher E, Scapa E, Wolf I, Orbach L, Brazowski E, Isakov O, Klausner JM, Lubezky N. Barenboim A, et al. Among authors: geva r. J Gastrointest Surg. 2020 Jun;24(6):1366-1374. doi: 10.1007/s11605-019-04285-y. Epub 2019 Jun 13. J Gastrointest Surg. 2020. PMID: 31197692

5

Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis.

Meyerovich G, Goykhman Y, Nakache R, Nachmany I, Lahat G, Shibolet O, Menachem Y, Katchman H, Wolf I, Geva R, Klausner JM, Lubezky N. Meyerovich G, et al. Among authors: geva r. Transplant Proc. 2019 Jul-Aug;51(6):1867-1873. doi: 10.1016/j.transproceed.2019.02.030. Transplant Proc. 2019. PMID: 31399171

6

Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.

Peleg Hasson S, Salwen B, Sivan A, Shamai S, Geva R, Merimsky O, Raphael A, Shmilovich H, Moshkovits Y, Kapusta L, Rozenbaum Z, Wolf I, Laufer-Perl M. Peleg Hasson S, et al. Among authors: geva r. Clin Res Cardiol. 2021 Jan;110(1):50-60. doi: 10.1007/s00392-020-01648-3. Epub 2020 Apr 15. Clin Res Cardiol. 2021. PMID: 32296970

7

Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.

Golan T, Barenboim A, Lahat G, Nachmany I, Goykhman Y, Shacham-Shmueli E, Halpern N, Brazowski E, Geva R, Wolf I, Goldes Y, Ben-Haim M, Klausner JM, Lubezky N. Golan T, et al. Among authors: geva r. Ann Surg Oncol. 2020 Oct;27(10):3963-3970. doi: 10.1245/s10434-020-08469-8. Epub 2020 Apr 20. Ann Surg Oncol. 2020. PMID: 32314163

8

First-in-human phase 1 study of MK-1248, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, as monotherapy or with pembrolizumab in patients with advanced solid tumors.

Geva R, Voskoboynik M, Dobrenkov K, Mayawala K, Gwo J, Wnek R, Chartash E, Long GV. Geva R, et al. Cancer. 2020 Nov 15;126(22):4926-4935. doi: 10.1002/cncr.33133. Epub 2020 Aug 18. Cancer. 2020. PMID: 32809217 Free article. Clinical Trial.

9

Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer.

Hasson SP, Waissengrin B, Shachar E, Hodruj M, Fayngor R, Brezis M, Nikolaevski-Berlin A, Pelles S, Safra T, Geva R, Wolf I. Hasson SP, et al. Among authors: geva r. Oncologist. 2021 Apr;26(4):e679-e685. doi: 10.1002/onco.13676. Epub 2021 Feb 1. Oncologist. 2021. PMID: 33453121 Free PMC article.

10

Effect of cannabis on oxaliplatin-induced peripheral neuropathy among oncology patients: a retrospective analysis.

Waissengrin B, Mirelman D, Pelles S, Bukstein F, Blumenthal DT, Wolf I, Geva R. Waissengrin B, et al. Among authors: geva r. Ther Adv Med Oncol. 2021 Feb 9;13:1758835921990203. doi: 10.1177/1758835921990203. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33613702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters